Uncovers shortcut bias in neoantigen prediction, indicating improvement opportunities in personalized cancer therapy.
Accurate neoantigen prediction is central to the design of personalized cancer immunotherapy. The immune recognition of neoantigens is a multi-step process involving peptide-major histocompatibility complex (MHC) binding, antigen presentation, and T cell activation. Despite extensive computational efforts, the overall accuracy of neoantigen identification remains unsatisfactory, limiting translational potential. Here, we present ImmUni, a unified transformer-based framework that models the three immunological stages within a consistent architecture. Through this unified modeling, we discovered that deep-learning-based immunogenicity predictors have inadvertently learned shortcut correlations driven by intra-human leukocyte antigen (intra-HLA) label imbalance, revealing a previously unrecognized model-agnostic source of bias. We quantified this bias using an information-theoretic metric and proposed a mutual-information-guided debiasing strategy that mitigates shortcut learning and improves mutation-level generalization. ImmUni not only identifies the shortcut bias issue in current neoantigen prediction but also defines a general methodological framework for diagnosing and correcting bias across data-limited, multi-step tasks in computational biology scenarios.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: